Dosidal · Switzerland

Eribulin Advanz Pharma, Injektionslösung

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketSwitzerland
Recordch:authorisation:69924 (version 1)
Levelauthorisation
Pack codenot anchored
Identifiersswissmedic-authorisation: 69924
atc: L01XX41
Source authoritySwissmedic
Read date
authorisation statusfirst_authorisation: 2025-06-26
term: zugelassen
valid_until: 2030-06-25
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
identityatc: L01XX41
authorisation_number: 69924
form: LSINJ
holder: Advanz Pharma Specialty Medicine
holder_partner_nr: 1101402
it_number: 07.16.1.
name: Eribulin Advanz Pharma, Injektionslösung
state: current · read 2026-11-15T01:25:13Z · source: Swissmedic (OGD) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
vRGWlt9audA_7rf_axEQfNfNjixAUF6nkGg6rBXh83aV9ypHSaK-C4zsLYxxdgoSE_bzvFoVMwa6batB7s35PQ
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/ch:authorisation:69924 · Related records in other markets · Dosidal